A novel, solvent extractable, antibiotic complex has been purified from the fermentation broth of an unusual member of the genus Streptosporangium.
In our continuing search for novel antibiotics from actinomycetes, a novel solvent extractable antibiotic complex has been obtained from the fermentation broth of an organism identified as a member of the genus Streptosporangium. The antibiotic producing organism was isolated from a soil sample collected in the Guatemalan jungle and has been deposited in the Schering Central Culture Collection under the accession number 1656. In addition to its antibiotic production, this organism has the ability to produce large amounts of iodinin1), both on agar and in broth. Detailed taxonomic analysis will be presented in a forthcoming paper.
The present paper describes the fermentation, isolation, structure elucidation and biological properties of the two major components of this antibiotic complex.
Fermentation
The inoculum for antibiotic production was prepared in a medium containing yeast extract 0.5 %, Cerelose 0.5%, dextrin 3%, corn steep flour 0.5% and cobalt chloride 0.024%. The pH of the medium was adjusted to 7.0 prior to sterilization. A 300-ml Erlenmeyer flask containing 50 ml of this medium was inoculated with 5 ml of a stock suspension of the producing strain which had been maintained at -20'C . The flask was incubated at 30°C, on a rotary shaker at 300 rpm, for 72 hours. The resulting seed culture was transferred to a 2-liter Erlenmeyer flask containing 500 ml of the above medium and incubated as above. The entire contents were used to inoculate a 14-liter New Brunswick Scientific laboratory fermentor containing 10 liters of the same medium.
The fermentation was carried out at 30°C with 10 liters of air per minute and agitation at 350 rpm.
Total antibiotic activity was monitored at regular intervals by bioassay against Candida albicans. The pH, dissolved oxygen levels, and growth profile of the organism during fermentation were also monitored ( Fig. 1) .
The whole broth from six, 10-liter, fermentations was extracted twice with equal volumes of ethyl acetate. The solvent layer was concentrated to an oil and precipitated with petroleum ether. The resulting reddish purple solid (2 g) was filtered and dried under vacuum. Silica gel thin-layer chromatography of the complex in benzene -methanol (9: 1) followed by bioautography against C. albicans resulted in four biologically active components. The components were labelled 1 through 4 based on decreasing Rf values.
Components 3 and 4, the major components, were purified by column chromatography on neutral alumina utilizing chloroform -methanol -water (2: 2: 1, lower phase) as the eluting solvent. The active fractions were monitored by thin-layer chromatography on silica gel, using benzene -methanol (9: 1) as the developing system, followed by bioautography against C. albicans. The fractions containing either component 3 or 4 were combined and concentrated. Crystallization of both components 3 and 4 from methylene chloride yielded 504 mg of pale yellow crystals (component 3) and 160 mg of reddish purple crystals (component 4). (Fig. 3) ; UV i.MeOH max (e) 275 (71,300), 377 (4,950), 440 (3,400) (Fig. 4) ; UV MeOH max+0.1N NaOH nm 265 (22,800), 296 (64,900) (Fig. 4) 6 110.9 (C-7), 115.6 (C-2), 118.8, 120.6 (C-9, 4), 132.1 (2C-3, 8) , 135.1, 135.7 (C-5a, 10a), 140.6, 142.1 (C-4a, 9a), 148.9 (C-1), 153.6 (C-6) (Fig. 7) . The UV spectrum clearly indicated that component 4 was a phenazine type compound.
3) The mass spectrum and chemical analysis showed that component 4 contained a chlorine atom. Analysis of the 1H and 13C NMR spectra could only be interpreted by placing the chlorine atom at position 2. high protein binding.
There was no significant antibacterial activity found in components 3 and 4.
The in vivo topical activity of component 4 was determined against a vaginal C. albicans infection in hamsters4). Treatment was as an intravaginal insert once daily for 8 days and the results are shown in Table 2 . Component 4 was inactive in this model.
Intravenous LD50s of both components determined in mice were greater than 100 mg/kg. a Sabouraud dextrose broth . b 4 % Bovine serum albumin approximates the concentration of albumin in whole serum . 
